2.300GBp+21.05%Mkt Cap: 10.93M $P/E: —1d ago
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs …
Indicators:|
Key Statistics
Company
Market Cap10.93M $
Enterprise Value10.49M $
Revenue (TTM)3.59M $
Gross Profit1.30M $
Net Income (TTM)-22.17M $
Revenue/Share0.0098 USD
Last Price2.300 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees46
CountryGB
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.26
PEG—
EV/EBITDA—
EV/Revenue2.92
P/S3.05
P/B-10.12
EPS (TTM)-0.03
EPS (Forward)-0.09
52W Range
1.6005% of range15.50
52W High15.50 GBp
52W Low1.600 GBp
Profitability
Gross Margin40.00%
Oper. Margin-437.50%
EBITDA Margin0.00%
Profit Margin-680.00%
ROE291.43%
ROA-334.43%
Growth
Revenue Growth2.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.46M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-434.78K $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-1.19
Current Ratio1.57
Quick Ratio1.39
Book Value/Sh-0.0023 GBp
Cash/Share0.0140 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.437.02M
Float363.95M
Insiders26.69%
Institutions50.80%
Technical
SMA 501.837 (+25.2%)
SMA 2004.753 (-51.6%)
Beta1.81
S&P 52W Chg20.05%
Avg Vol (30d)427.85K
Avg Vol (10d)249.47K
Technical Indicators
RSI (14)95.1
MACD0.0409
MACD Signal0.0086
MACD Hist.+0.0323
BB Upper2.098 GBp
BB Middle1.893 GBp
BB Lower1.687 GBp
BB Width21.76%
ATR (14)0.2373 GBp
Vol Ratio (20d)11.55x